Per Olav Vandvik
Overview
Explore the profile of Per Olav Vandvik including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
161
Citations
5909
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nagraj S, Hafver T, Hohlfeld A, Effa E, Mabetha D, Kunje G, et al.
Clin Public Health Guidel
. 2025 Mar;
2(2):e70012.
PMID: 40070372
Clinical practice guidelines (CPGs) are shared through various dissemination strategies using a range of dissemination products and channels. However, users may have different needs for accessing and understanding them. Patients...
2.
Barnard-Kelly K, Battelino T, Brosius F, Ceriello A, Cosentino F, Gavin 3rd J, et al.
Cardiovasc Diabetol
. 2025 Feb;
24(1):68.
PMID: 39920737
Recent clinical practice guidelines for diabetes, obesity, cardiovascular disease (CVD) and chronic kidney disease (CKD) emphasise a holistic, person-centred approach to care. However, they do not include recommendations for the...
3.
Zeraatkar D, Pitre T, Kirsh S, Jassal T, Ling M, Hussain M, et al.
BMJ Med
. 2024 Nov;
3(1):e000998.
PMID: 39574425
Objective: To address the efficacy and safety of proactive therapeutic drug monitoring of biologic drugs for patients with inflammatory bowel disease, inflammatory arthritis, and psoriasis. Design: Systematic review and meta-analysis....
4.
Zou X, Shi Q, Vandvik P, Mao Y, Agarwal A, Ponte B, et al.
BMJ Med
. 2024 Nov;
3(1):e001009.
PMID: 39574422
Objective: To examine cardiovascular and kidney benefits and harms of sodium-glucose co-transporter-2 (SGLT-2) inhibitors stratified by risk in adults with chronic kidney disease regardless of diabetes status. Design: Systematic review...
5.
Kawano-Dourado L, Kristianslund E, Zeraatkar D, Jani M, Makharia G, Hazlewood G, et al.
BMJ
. 2024 Oct;
387:e079830.
PMID: 39467592
Clinical Question: In adult patients with inflammatory bowel disease, inflammatory arthritis (rheumatoid arthritis, spondyloarthritis, psoriatic arthritis), or psoriasis taking biologic drugs, does proactive therapeutic drug monitoring (TDM) improve outcomes as...
6.
Agarwal A, Zeng X, Li S, Rayner D, Foroutan F, Aertgeerts B, et al.
BMJ
. 2024 Oct;
387:e080257.
PMID: 39353639
Clinical Question: What is the impact of sodium-glucose cotransporter-2 (SGLT-2) inhibitors on survival and on cardiovascular and kidneyoutcomes for adults living with chronic kidney disease (CKD)? Current Practice: Few therapies...
7.
Hassan C, Rizkala T, Mori Y, Spadaccini M, Misawa M, Antonelli G, et al.
Lancet Gastroenterol Hepatol
. 2024 Sep;
9(11):1010-1019.
PMID: 39303733
Background: The resect-and-discard strategy allows endoscopists to replace post-polypectomy pathology with real-time prediction of polyp histology during colonoscopy (optical diagnosis). We aimed to investigate the benefits and harms of implementing...
8.
Kredo T, Effa E, Mbeye N, Mabetha D, Schmidt B, Rohwer A, et al.
Health Res Policy Syst
. 2024 Aug;
22(1):114.
PMID: 39160559
Background: Poverty-related diseases (PRD) remain amongst the leading causes of death in children under-5 years in sub-Saharan Africa (SSA). Clinical practice guidelines (CPGs) based on the best available evidence are...
9.
Lovsletten P, Wang X, Pitre T, Odegaard M, Veroniki A, Lunny C, et al.
J Clin Epidemiol
. 2024 Jun;
173():111445.
PMID: 38942177
Objectives: To map whether and how systematic reviews (SRs) with network meta-analysis (NMA) use presentation formats to report (a) structured evidence summaries - here defined as reporting of effects estimates...
10.
Lovsletten P, Hunskaar B, Heen A, Bekkering G, Poel L, Zeraatkar D, et al.
J Clin Epidemiol
. 2024 May;
172:111399.
PMID: 38810842
Objectives: To evaluate and improve "Making Alternative Treatment Choices Intuitive and Trustworthy" (MATCH-IT)-a digital, interactive decision support tool displaying structured evidence summaries for multiple comparisons-to help physicians interpret and apply...